(Q38880714)

7 September 2017

title

Genetic and molecular analyses reveal G6PC as a key element connecting glucose metabolism and cell cycle control in ovarian cancer (English)

1 reference

7 September 2017

0 references

1 reference

Ting Guo

1

1 reference

7 September 2017

Tao Chen

2

1 reference

7 September 2017

Chao Gu

3

1 reference

7 September 2017

Bin Li

4

1 reference

7 September 2017

Congjian Xu

5

1 reference

7 September 2017

publication date

30 April 2015

1 reference

7 September 2017

1 reference

7 September 2017

volume

36

1 reference

7 September 2017

issue

10

1 reference

7 September 2017

page(s)

7649-7658

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-3463-6

7 September 2017

exact match

0 references

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

Fructose-1,6-bisphosphatase opposes renal carcinoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

Comprehensive molecular characterization of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

Glucose-6-phosphatase is a key metabolic regulator of glioblastoma invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

Identification of two novel and potent competitive inhibitors of the glucose-6-phosphatase catalytic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

Mechanisms of resistance to therapies targeting BRCA-mutant cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

Serum lactate dehydrogenase predicts for overall survival benefit in patients with metastatic renal cell carcinoma treated with inhibition of mammalian target of rapamycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

Reducing confounding and suppression effects in TCGA data: an integrated analysis of chemotherapy response in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

RETRACTED: Gene-gene interaction network analysis of ovarian cancer using TCGA data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

Glycolytic genes in cancer cells are more than glucose metabolic regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

Established and new mouse models reveal E2f1 and Cdk2 dependency of retinoblastoma, and expose effective strategies to block tumor initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3463-6

Glucose-6-phosphatase catalytic enzyme inhibitors: synthesis and in vitro evaluation of novel 4,5,6,7-tetrahydrothieno[3,2-c]- and -[2,3-c]pyridines

21 January 2018

1 reference

12 December 2020

Forkhead Box O1 is present in quiescent pituitary cells during development and is increased in the absence of p27 Kip1

1 reference

12 December 2020

Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment

1 reference

12 December 2020

Clinical relevance of gain-of-function mutations of p53 in high-grade serous ovarian carcinoma

1 reference

12 December 2020

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

1 reference

12 December 2020

Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers

1 reference

12 December 2020

Integrated analysis of gene expression profiles associated with response of platinum/paclitaxel-based treatment in epithelial ovarian cancer

1 reference

12 December 2020

The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin

1 reference

12 December 2020

10.1007/S13277-015-3463-6

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1029053318

0 references

1 reference